Thailand · Delayed Price · Currency is THB Bio Green Energy Tech PCL Statistics
Total Valuation
BKK:BIOTEC has a market cap or net worth of THB 1.07 billion. The enterprise value is 1.43 billion.
| Market Cap | 1.07B |
| Enterprise Value | 1.43B |
Important Dates
The last earnings date was Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
BKK:BIOTEC has 3.05 billion shares outstanding.
| Current Share Class | 3.05B |
| Shares Outstanding | 3.05B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 45.68% |
| Owned by Institutions (%) | 0.02% |
| Float | 1.06B |
Valuation Ratios
The trailing PE ratio is 37.42.
| PE Ratio | 37.42 |
| Forward PE | n/a |
| PS Ratio | 0.25 |
| PB Ratio | 0.97 |
| P/TBV Ratio | 2.43 |
| P/FCF Ratio | 6.15 |
| P/OCF Ratio | 5.57 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.60, with an EV/FCF ratio of 8.20.
| EV / Earnings | 49.90 |
| EV / Sales | 0.34 |
| EV / EBITDA | 10.60 |
| EV / EBIT | 52.68 |
| EV / FCF | 8.20 |
Financial Position
The company has a current ratio of 0.57, with a Debt / Equity ratio of 0.41.
| Current Ratio | 0.57 |
| Quick Ratio | 0.32 |
| Debt / Equity | 0.41 |
| Debt / EBITDA | 3.36 |
| Debt / FCF | 2.59 |
| Interest Coverage | 0.72 |
Financial Efficiency
Return on equity (ROE) is 2.68% and return on invested capital (ROIC) is 1.23%.
| Return on Equity (ROE) | 2.68% |
| Return on Assets (ROA) | 0.67% |
| Return on Invested Capital (ROIC) | 1.23% |
| Return on Capital Employed (ROCE) | 1.94% |
| Weighted Average Cost of Capital (WACC) | 3.09% |
| Revenue Per Employee | 20.94M |
| Profits Per Employee | 142,086 |
| Employee Count | 201 |
| Asset Turnover | 1.69 |
| Inventory Turnover | 17.08 |
Taxes
In the past 12 months, BKK:BIOTEC has paid 12.75 million in taxes.
| Income Tax | 12.75M |
| Effective Tax Rate | 30.30% |
Stock Price Statistics
The stock price has increased by +60.00% in the last 52 weeks. The beta is -0.41, so BKK:BIOTEC's price volatility has been lower than the market average.
| Beta (5Y) | -0.41 |
| 52-Week Price Change | +60.00% |
| 50-Day Moving Average | 0.19 |
| 200-Day Moving Average | 0.19 |
| Relative Strength Index (RSI) | 78.93 |
| Average Volume (20 Days) | 23,607,771 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BKK:BIOTEC had revenue of THB 4.21 billion and earned 28.56 million in profits. Earnings per share was 0.01.
| Revenue | 4.21B |
| Gross Profit | 159.11M |
| Operating Income | 26.77M |
| Pretax Income | 42.07M |
| Net Income | 28.56M |
| EBITDA | 116.29M |
| EBIT | 26.77M |
| Earnings Per Share (EPS) | 0.01 |
Balance Sheet
The company has 100.52 million in cash and 450.66 million in debt, with a net cash position of -350.14 million or -0.11 per share.
| Cash & Cash Equivalents | 100.52M |
| Total Debt | 450.66M |
| Net Cash | -350.14M |
| Net Cash Per Share | -0.11 |
| Equity (Book Value) | 1.10B |
| Book Value Per Share | 0.36 |
| Working Capital | -370.17M |
Cash Flow
In the last 12 months, operating cash flow was 191.95 million and capital expenditures -18.26 million, giving a free cash flow of 173.69 million.
| Operating Cash Flow | 191.95M |
| Capital Expenditures | -18.26M |
| Depreciation & Amortization | 89.53M |
| Net Borrowing | -552.67M |
| Free Cash Flow | 173.69M |
| FCF Per Share | 0.06 |
Margins
Gross margin is 3.78%, with operating and profit margins of 0.64% and 0.70%.
| Gross Margin | 3.78% |
| Operating Margin | 0.64% |
| Pretax Margin | 1.00% |
| Profit Margin | 0.70% |
| EBITDA Margin | 2.76% |
| EBIT Margin | 0.64% |
| FCF Margin | 4.13% |
Dividends & Yields
BKK:BIOTEC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | 2.67% |
| FCF Yield | 16.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BKK:BIOTEC has an Altman Z-Score of 1.71 and a Piotroski F-Score of 8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.71 |
| Piotroski F-Score | 8 |